On July 19, 2019, RavenQuest BioMed Inc. (CNSX:RQB) amended the terms of the transaction. On the same date, the company issued 907,000 units for gross proceeds of CAD 453,500 in its second and final tranche. The company issued a total of 5,047,000 units for gross proceeds of CAD 2,523,500 in the transaction. The company paid a finders fees of CAD 162,645 in cash and issued 325,290 warrants in relation to the transaction.